Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alterations in Muscle Tone ll

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Emergence of Task-Related Motor Cortical Dysfunction in Mice with Progressive Parkinsonism.

bioRxiv : the preprint server for biology·2026

Same author

Temporal Variability in the Spiking Activity of Neurons in the External Globus Pallidus in Healthy and Parkinsonian Monkeys.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026

Same author

Subthalamic nucleus in patients with Parkinson's disease encodes changes and magnitude of applied force.

NPJ Parkinson's disease·2026

Same author

Enhanced beta power emerges from simulated parkinsonian primary motor cortex.

NPJ Parkinson's disease·2025

Same author

Microendoscopic calcium imaging in motor cortices of macaques during rest and movement.

iScience·2025

Same author

Modeling characteristics of neuronal firing in the thalamocortical network of connections in control and parkinsonian primates.

Journal of computational neuroscience·2025

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Commentary: Dopaminergic dysfunction in DYT1 dystonia.

Thomas Wichmann¹

¹Department of Neurology/School of Medicine and Yerkes National Primate Research Center, Emory University, 954 Gatewood Road NE, Atlanta, GA 30329, USA. twichma@emory.edu

Experimental Neurology

|June 3, 2008

Summary

Generalized torsion dystonia (DYT1) is caused by a torsinA gene mutation. A new mouse model overexpressing human mutant torsinA suggests dopamine dysfunction may play a role in this movement disorder.

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

Related Experiment Videos

Last Updated: Jul 4, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

Area of Science:

Neuroscience
Genetics
Movement Disorders

Background:

Generalized torsion dystonia (DYT1) is a severe inherited movement disorder caused by a specific mutation in the torsinA gene.
The condition disrupts voluntary movements, leading to sustained muscle spasms and abnormal postures.
Understanding the genetic and molecular basis of DYT1 is crucial for developing effective treatments.

Discussion:

A recent study characterized a transgenic mouse model overexpressing human mutant torsinA.
The research focused on behavioral, anatomical, and biochemical aspects, particularly investigating dopaminergic dysfunction.
This commentary reviews human DYT1 features and available mouse models, discussing dopamine's potential role.

Key Insights:

A three-base-pair deletion in the torsinA gene is the primary cause of DYT1 dystonia.
Transgenic mice overexpressing human mutant torsinA exhibit characteristics relevant to human DYT1.
Evidence suggests a significant role for dopaminergic system dysfunction in the manifestation of DYT1 symptoms.

Outlook:

Further research on this mouse model can elucidate DYT1 pathophysiology.
Investigating dopaminergic pathways may reveal therapeutic targets for DYT1 dystonia.
Developing better animal models is essential for preclinical testing of novel DYT1 treatments.